2007
DOI: 10.1016/j.bone.2006.11.023
|View full text |Cite
|
Sign up to set email alerts
|

Jaw osteonecrosis related to bisphosphonate therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
53
0
12

Year Published

2007
2007
2017
2017

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 102 publications
(66 citation statements)
references
References 35 publications
1
53
0
12
Order By: Relevance
“…41 In addition, we did not observe any cases of osteonecrosis of the jaw in our patients after the bisphosphonate treatment, which has been described previously. [42][43][44] This may be due to the relatively small number of bisphosphonate-treated patients in our study or to other factors such as the association of extended intravenous bisphosphonate therapy with osteonecrosis.…”
Section: Discussionmentioning
confidence: 99%
“…41 In addition, we did not observe any cases of osteonecrosis of the jaw in our patients after the bisphosphonate treatment, which has been described previously. [42][43][44] This may be due to the relatively small number of bisphosphonate-treated patients in our study or to other factors such as the association of extended intravenous bisphosphonate therapy with osteonecrosis.…”
Section: Discussionmentioning
confidence: 99%
“…The duration of bisphosphonate therapy is also an important factor which relates to the likelihood of developing BRONJ. In addition, the more potent nitrogen-containing bisphosphonates, such as pamidronate and zolendronate, are more often associated with the development of BRONJ than the oral bisphosphonate formulations [16][17][18][19][20][21][22][23][24][25]. An important paper published recently by Corso et al [44] has highlighted the importance of reducing the schedule of zolendronic acid in order to lower the risk of BRONJ in patients with multiple myeloma.…”
Section: Pathogenesis and Risk Factorsmentioning
confidence: 99%
“…Special stains such as PAS and Gram staining can be useful to further confirm the findings. Several authors have found a striking high presence of Actinomyces in necrotic bone areas and considered these pathogens to be involved in the chronic, non-healing process of BRONJ [12,19,25,31,42]. It should be noted that Actinomyces are commonly present as commensals in the oral cavity thus their presence within the necrotic lesions is likely not an etiological factor in the pathogenesis of BRONJ, but rather a secondary infection of the necrotic tissues [31,46].…”
Section: Pathological Aspectsmentioning
confidence: 99%
See 2 more Smart Citations